Cargando…

The role of oestrogen and progesterone receptors in breast cancer – immunohistochemical evaluation of oestrogen and progesterone receptor expression in invasive breast cancer in women

AIM OF THE STUDY: Expression of oestrogen and progesterone receptors is a very powerful and useful predictor. Because the response rate to hormonal treatment in breast cancer is associated with the presence of oestrogen and progesterone receptors, assessment of the receptor expression profile allows...

Descripción completa

Detalles Bibliográficos
Autores principales:	Badowska-Kozakiewicz, Anna M., Patera, Janusz, Sobol, Maria, Przybylski, Jacek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2015
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631285/ https://www.ncbi.nlm.nih.gov/pubmed/26557763 http://dx.doi.org/10.5114/wo.2015.51826

Ejemplares similares

Immunohistochemical evaluation of human epidermal growth factor receptor 2 and estrogen and progesterone receptors in invasive breast cancer in women
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2012)

Oestrogen and progesterone receptor distribution in the cancerous breast.
por: Panahy, C., et al.
Publicado: (1987)

Alcohol consumption and breast cancer oestrogen and progesterone receptor status
por: Enger, S M, et al.
Publicado: (1999)

The role of oestrogen and progesterone receptors in gigantomastia
por: Kasielska-Trojan, Anna, et al.
Publicado: (2019)

Risk factors for breast cancer in young women by oestrogen receptor and progesterone receptor status
por: McCredie, M R E, et al.
Publicado: (2003)

Oestrogen and progesterone receptors and disease-free interval in primary breast cancer.
por: Alanko, A., et al.
Publicado: (1984)

Oestrogen increases S-phase fraction and oestrogen and progesterone receptors in human cervical cancer in vivo.
por: Bhattacharya, D., et al.
Publicado: (1997)

Oestrogen receptor-negative/progesterone receptor-positive phenotype of invasive breast carcinoma in Japan: re-evaluated using immunohistochemical staining
por: Kuroda, Hajime, et al.
Publicado: (2018)

Oestrogen receptor isoforms, their distribution and relation to progesterone receptor levels in breast cancer samples.
por: Baker, V. A., et al.
Publicado: (1992)

The impact of progesterone receptor negativity on oncological outcomes in oestrogen-receptor-positive breast cancer
por: Davey, M G, et al.
Publicado: (2021)

Oestrogen and progesterone cytosolic receptors in clinically inflammatory tumours of the human breast.
por: Delarue, J. C., et al.
Publicado: (1981)

The effect of oestrogen and progesterone receptors on recurrence and survival in patients with carcinoma of the breast.
por: Howat, J. M., et al.
Publicado: (1985)

Progesterone receptors – animal models and cell signaling in breast cancer: The role of oestrogen and progesterone receptors in human mammary development and tumorigenesis
por: Anderson, Elizabeth
Publicado: (2002)

Reproductive risk factors and oestrogen/progesterone receptor-negative breast cancer in the Breast Cancer Family Registry
por: Work, M E, et al.
Publicado: (2014)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer
por: Xu, Wei, et al.
Publicado: (2020)

The association of cytosol oestrogen and progesterone receptors with histological features of breast cancer and early recurrence of disease.
por: Howat, J. M., et al.
Publicado: (1983)

Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2022)

Intrathoracic myolipoma from parietal pleura with oestrogen and progesterone receptor
por: Teh, Jyh Shinn, et al.
Publicado: (2021)

The Role of CHK1 Varies with the Status of Oestrogen-receptor and Progesterone-receptor in the Targeted Therapy for Breast Cancer : Erratum
por: Xu, Wei, et al.
Publicado: (2021)

Plasma oestrogens and oestrogen receptors in breast cancer patients.
por: Mason, R. C., et al.
Publicado: (1985)

MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer
por: Lowery, Aoife J, et al.
Publicado: (2009)

Expression of oestrogen and progesterone receptors in gastric cancer: a flow cytometric study
por: Karat, D, et al.
Publicado: (1999)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

Author Correction: Activation function 1 of progesterone receptor is required for progesterone antagonism of oestrogen action in the uterus
por: Lee, Shi Hao, et al.
Publicado: (2023)

Crumbs protein homolog 3 (CRB3) expression is associated with oestrogen and progesterone receptor positivity in breast cancer
por: Li, Pingping, et al.
Publicado: (2019)

Evaluation of Expression of the PTEN Gene, Oestrogen and Progesterone Receptors as Diagnostic and Predictive Factors in Endometrial Cancer
por: Samulak, Dariusz, et al.
Publicado: (2013)

Insulin receptor substrate-1 (IRS-1) mediates progesterone receptor-driven stemness and endocrine resistance in oestrogen receptor+ breast cancer
por: Dwyer, Amy R., et al.
Publicado: (2020)

Relationship between the expression of oestrogen receptor and progesterone receptor and (18)F-FDG uptake in endometrial cancer
por: Wu, Chunhua, et al.
Publicado: (2020)

Oestrogens and oestrogen receptors in prostate cancer
por: Kowalska, Karolina, et al.
Publicado: (2016)

Oestrogen receptors in primary breast cancer.
por: Williams, M. R., et al.
Publicado: (1985)

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b
por: Snell, Cameron E., et al.
Publicado: (2018)

Retrospective evaluation of histopathological examinations in invasive ductal breast cancer of no special type: an analysis of 691 patients
por: Badowska-Kozakiewicz, Anna M., et al.
Publicado: (2016)

Is oestrogen receptor-negative/progesterone receptor-positive (ER−/PR+) a real pathological entity?
por: Onitilo, Adedayo A, et al.
Publicado: (2021)

The additional value of ONEST (Observers Needed to Evaluate Subjective Tests) in assessing reproducibility of oestrogen receptor, progesterone receptor, and Ki67 classification in breast cancer
por: Cserni, Bálint, et al.
Publicado: (2021)

The origins of oestrogen receptor negative breast cancer
por: Allred, D Craig
Publicado: (2007)

Proceedings: Oestrogen receptors in human breast cancer.
por: Leclercq, G., et al.
Publicado: (1974)

Elastosis and oestrogen receptors in human breast cancer.
por: Masters, J. R., et al.
Publicado: (1976)

Effect of tamoxifen on Ki67 labelling index in human breast tumours and its relationship to oestrogen and progesterone receptor status.
por: Clarke, R. B., et al.
Publicado: (1993)

Immunohistochemical evaluation of oestrogen receptors α and β in epithelium of the vaginal mucous membrane in women after oestrogen therapy
por: Sawczuk, Beata, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_ntn7i5r17u8lclpp8t4gn9q7h2